Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-697P (RNA, U6 small nuclear 697, pseudogene) is annotated as a non-protein-coding RNA and specifically as a pseudogene derived from the U6 small nuclear RNA (snRNA) sequence[4]. Pseudogenes are genomic sequences similar to known functional genes but are generally nonfunctional; they do not code for active RNAs or proteins and often lack biological function due to disabling mutations or lack of transcriptional machinery[2]. The U6 snRNA family is a highly conserved group of non-coding RNAs essential for pre-mRNA splicing as a catalytic RNA within the spliceosome[1][3]; however, RNU6-697P, as a pseudogene, does not have a known functional role in RNA splicing or any other biological process, nor is it a receptor, enzyme, or druggable target[4]. There are no known disease associations, biomarker uses, drug interactions, or therapeutic implications for this pseudogene. Its presence in the genome likely reflects evolutionary remnants of U6 snRNA gene sequences, and it should not be considered a molecular target for therapeutics or diagnostics[4][3]. This entry is best classified as a non-functional pseudogene, not a molecular target or receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 697, pseudogene (RNU6-697P).